Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.
Saved in:
| Main Authors: | İrem Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M. Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkiprik |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2024/6117394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate
by: Gökçe Güllü Amuran, et al.
Published: (2024-11-01) -
Impact of Liquid Biopsy Preanalytics on cfDNA Fragmentation Analyses
by: A. Hallermayr, et al.
Published: (2023-11-01) -
Somatic Mutation Calling from cfDNA Using Machine Learning
by: S. Akbarinejad, et al.
Published: (2023-11-01) -
Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
by: Yidan Ma, et al.
Published: (2024-09-01) -
Impact of cfDNA Input on Enzymatic Methylation Conversion and Library Preparation Robustness
by: U. Kunej, et al.
Published: (2023-11-01)